The ruling removes a barrier to a deal the FTC claims will eliminate competition in the outsourced hydrophilic coatings ...

The lowest level of quarterly VC funding since 2023 has tempered expectations that the sector will achieve its best year ...

The company also posted weaker third-quarter results, but CEO David Fischel said orders for the new GenesisX system, when ...

MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass ...

Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.

More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent ...

The collaboration will pair biometric data from the Oura ring with data from glucose sensors and insulin pumps.

Siemens Healthineers has reaffirmed its expectation that the negative impact of tariffs will double in its next fiscal year ...

Several justices seemed skeptical of the Trump administration's claims of broad tariff authority under a 1977 emergency ...

The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall. Zimmer Biomet reported ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.